3- [N-tris (hydroxymethyl) methylamino] -2-hydroxypropylsulfonic acid sodium (TAPSO-NA) NEW

Hubei New Desheng Materials Technology Co., Ltd is a professional research and development, production and sales of blood test reagents. The company has established sales center, production center, research and development department, quality department, finance department, comprehensive management department and other institutions. At present, the company has six main series of products, blood collection tube additives, biological buffers, chemiluminescent reagents, new Trinder's reagents, enzymes Preparations, antigens and antibodies. The company has annual sales of more than 20 million yuan and more than 400 domestic and foreign customers. The company's products and services are widely recognized and affirmed by domestic and foreign customers. It has become the preferred service provider and supplier for industry customers, and the market develops at a rate of about 20% every year. The company focuses on the blood test reagent industry and is determined to become the world's leading brand in this industry, contributing to the cause of human health. Since the establishment of the company, it has always adhered to and adhered to the core business philosophy of "based on virtue, and sincerity first". It has been our responsibility to provide value to customers and has been well received by customers. The core advantages of the company's products: the stability, consistency and suitability of quality, and the stability and consistency of product quality as the core elements of quality control. To this end, the company continuously improves the process, equipment, environment, and raw materials, and trains personnel on quality awareness and skill training to ensure the stability and consistency of product quality. At the same time, to make products of appropriate quality, the quality and performance must be fully guaranteed but not excessive, otherwise it will increase customer costs and reduce market competitiveness; industry needs: we have solved the conveni